| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DXCM | Common Stock | Award | $2.91 | +2,906 | +74% | $0.001000* | 6,854 | 18 May 2023 | Direct | F1 |
| transaction | DXCM | Common Stock | Gift | $0 | -3,948 | -58% | $0.000000 | 2,906 | 18 May 2023 | Direct | F2 |
| transaction | DXCM | Common Stock | Gift | $0 | +3,948 | +12% | $0.000000 | 36,404 | 18 May 2023 | by Trust | F2, F3 |
| Id | Content |
|---|---|
| F1 | The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. |
| F2 | Shares were transferred from direct ownership to ownership under the Richard A. Collins Revocable Trust upon vesting of previously awarded restricted stock units. |
| F3 | Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee. |